Original Article

Association of Anemia with Outcomes of Acute Heart Failure

Authors: Ahmad Halawa, MD, M. Caroline Burton, MD, Michael J. Maniaci, MD, Brian P. Shapiro, MD, Daniel S. Yip, MD, David O. Hodge, , Emily R. Vargas, , Nancy Dawson, MD

Abstract

Objectives: Anemia is common in patients presenting with acute congestive heart failure (CHF); when hemoglobin (HGB) declines to low levels, it can result in worse outcomes. The aim of this study was to determine a level of HGB on admission or discharge that affects outcomes in patients with CHF and then to evaluate the effect of the low HGB levels on these outcomes.

Methods: We conducted a retrospective cohort study of 756 patients admitted with acute CHF during the period January 1, 2011–December 31, 2014. We used multivariable regression analysis to evaluate the relation among HGB levels and three major outcomes: 3-year mortality, 30-day readmission rate, and length of stay (LOS).

Results: Compared with patients with HGB ≥10 g/dL, patients with HGB <10 g/dL on discharge from the hospital had higher mortality (3-year survival 46% vs 33%, P = 0.023) and 30-day readmission rates (23% vs 14%; P = 0.008) and increased LOS (4.8 vs 3.2 days, P < 0.001). Patients with admission HGB <10 g/dL had higher mortality rates (3-year survival 45% vs 32%, P = 0.019) and increased LOS (4.5 vs 3.4 days, P = 0.014). A lower admission HGB value was associated with higher 30-day readmission rates, but it was not statistically significant (P = 0.06).

Conclusions: An HGB level <10 g/dL on admission or discharge in patients hospitalized with acute CHF is associated with a significantly worse outcome.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. O'Meara E, Murphy C, McMurray JJ. Anemia and heart failure. Curr Heart Fail Rep 2004;1:176-182.
 
2. Mentz RJ, Greene SJ, Ambrosy AP, et al. Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial. Circ Heart Fail 2014;7:401-408.
 
3. McCullough PA, Barnard D, Clare R, et al. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function. Clin Cardiol 2013;36:611-620.
 
4. O'Meara E, Rouleau JL, White M, et al. Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes. Circ Heart Fail 2014;7:773-781.
 
5. Anand IS, Rector TS. Pathogenesis of anemia in heart failure. Circ Heart Fail 2014;7:699-700.
 
6. Arora NP, Ghali JK. Anemia and iron deficiency in heart failure. Heart Fail Clin 2014;10:281-294.
 
7. Klip IT, Postmus D, Voors AA, et al. Hemoglobin levels and new-onset heart failure in the community. Am Heart J 2015;169:94-101.e2.
 
8. Oster HS, Benderly M, Hoffman M, et al. Mortality in heart failure with worsening anemia: a national study. Isr Med Assoc J 2013;15:368-372.
 
9. Caughey MC, Avery CL, Ni H, et al. Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance). Am J Cardiol 2014;114:1850-1854.
 
10. Pulignano G, Del Sindaco D, Di Lenarda A, et al. Chronic renal dysfunction and anaemia are associated with cognitive impairment in older patients with heart failure. J Cardiovasc Med (Hagerstown) 2014;15:481-490.
 
11. Reed SD, Li Y, Ellis SJ, et al. Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTION. J Card Fail 2012;18:784-791.
 
12. Qaseem A, Humphrey LL, Fitterman N, et al. Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2013;159:770-779.
 
13. Wakabayashi K, Sato N, Kajimoto K, et al. Incidence and predictors of in-hospital non-cardiac death in patients with acute heart failure. Eur Heart J Acute Cardiovasc Care 2017;6:441-449.
 
14. Kajimoto K, Sato N, Takano T. Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction. Eur Heart J Acute Cardiovasc Care 2016;5:89-99.
 
15. Kosiborod M, Smith GL, Radford MJ, et al. The prognostic importance of anemia in patients with heart failure. Am J Med 2003;114:112-119.
 
16. Stojcevski B, Celic V, Navarin S, et al. The use of discharge haemoglobin and NT-proBNP to improve short and long-term outcome prediction in patients with acute heart failure. Eur Heart J Acute Cardiovasc Care 2015; pii: 2048872615585521.
17. Caira C, Ansalone G, Mancone M, et al. Heart failure and iron deficiency anemia in Italy: results from CARMES-1 registry. Future Cardiol 2013;9:437-444.
 
18. Bolger AP, Bartlett FR, Penston HS, et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006;48:1225-1227.
 
19. Vaisman N, Silverberg DS, Wexler D, et al. Correction of anemia in patients with congestive heart failure increases resting energy expenditure. Clin Nutr 2004;23:355-361.
 
20. Simsek H, Gunes Y, Demir C, et al. The effects of iron deficiency anemia on p wave duration and dispersion. Clinics (Sao Paulo) 2010;65:1067-1071.